Skip to content

Nicorandil Stress Myocardial Perfusion SPECT Study compared with Adenosine Stress

Comparative Study on Effect of Pharmacological Stress with Nicorandil and Adenosine to Diagnostic Performance of Myocardial Perfusion SPECT in Ischemic Heart Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003432
Enrollment
50
Registered
2019-01-16
Start date
2017-09-25
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kangwon National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? suspected ischemic heart disease patient who will undergo coronary angiography a) previously healthy patient: no previous medical history with diagnosis of or treatment for coronary heart disease b) known ischemic heart disease patient: patient with new symptoms including chest pain, dyspnea, etc. within recent 1 month ? both male and female patients aged over 40

Exclusion criteria

Exclusion criteria: ? Severe renal failure, hepatic failure, brain function disorders, hypotension, cardiogenic shoke, or other physical or psycological problems that make the patient difficult to participate in the current study ? contraindications to adenosine or nicorandil as below: a) adenosine: hypersensitivity reaction, 2nd/3rd degree AV block, sick sinus syndrome, chronic obstructive pulmonary disease, long QT syndrome, severe hypotension, uncompensated heart failure, refractory unstable angina, dipyridamol use b) nicorandil: severe hepatic/renal dysfunction, severe brain dysfunction, severe hypotension or cardiogenic shock, Eisenmenger syndrome or primary hypertension, right ventricular infarction, dehydration symptoms, neurocirculatory asthenia, narrow angle glaucoma, history of hypersensitiveness to nicorandil or nitric acid/nitrite ester agents, use of phosphodiesterase-5 (PDE-5) or guanylate cyclase ? pregnancy or breast feeding

Design outcomes

Primary

MeasureTime frame
adverse effect: flushing, dyspnea, chest pain, gastrointestinal discomfort, headache, dizziness, hypotension, palpitation, weakness, nausea/vomiting, abdominal pain, back pain, toothache, nasal congestion, throat-neck discomfort, etc.;diagnostic performance for ischemic heart disease: sensitivity and specificity

Secondary

MeasureTime frame
Quantitative and semi-quantitative parameters from myocardial perfusion SPECT: left ventricular ejection fraction, myocardial blood flow udner rest (MBF-Re), myocardial blood flow udner stress (MBF-St), respectively), myocardial blood flow increasing rate (MBF-IR), sum of rest scores (SRS), sum of stress scores (SSS), sum of difference scores (SDS), etc.

Countries

Korea, Republic of

Contacts

Public ContactIn Kook Chun

Kangwon National University Hospital

inkook.chun@gmail.com+82-33-258-9041

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026